Paradoxical Tumefactive Worsening of Multiple Sclerosis After Natalizumab Initiation: A Case Report.
- Published in:
- touchREVIEWS in Neurology, 2023, v. 19, n. 2, p. 19, doi. 10.17925/USN.2023.19.2.25
- By:
- Publication type:
- Article
Works matching IS 27525465 AND DT 2023 AND VI 19 AND IP 2
Results: 7
1
2
A Rare Presentation of Steroid-responsive Encephalopathy Associated with Autoimmune Thyroiditis with Neuropsychiatric Symptoms: A Case Report.
- Published in:
- touchREVIEWS in Neurology, 2023, v. 19, n. 2, p. 16, doi. 10.17925/USN.2023.19.2.4
- By:
- Publication type:
- Article
3
Omaveloxolone for the Treatment of Friedreich’s Ataxia.
- Published in:
- touchREVIEWS in Neurology, 2023, v. 19, n. 2, p. 10, doi. 10.17925/USN.2023.19.2.2
- By:
- Publication type:
- Article
4
Updates in the Use of Vamorolone and Steroids in the Treatment of Duchenne Muscular Dystrophy.
- Published in:
- touchREVIEWS in Neurology, 2023, v. 19, n. 2, p. 1, doi. 10.17925/USN.2023.19.2.5
- By:
- Publication type:
- Article
5
Pridopidine: Topline Results from the Phase III Trial, PROOF- HD, for the Treatment of Huntington’s Disease.
- Published in:
- touchREVIEWS in Neurology, 2023, v. 19, n. 2, p. 4, doi. 10.17925/USN.2023.19.2.3
- By:
- Publication type:
- Article
6
The Future of SCN1A Gene-targeting Research for the Treatment of Dravet Syndrome.
- Published in:
- touchREVIEWS in Neurology, 2023, v. 19, n. 2, p. 2, doi. 10.17925/USN.2023.19.2.1
- By:
- Publication type:
- Article
7
Foreword.
- Published in:
- touchREVIEWS in Neurology, 2023, v. 19, n. 2, p. 1
- By:
- Publication type:
- Article